SeaStar Medical Holding Corp (ICU) with a beta value of -0.59 appears to be a promising investment opportunity.

SeaStar Medical Holding Corp (NASDAQ: ICU) on Tuesday, plunged -6.72% from the previous trading day, before settling in for the closing price of $1.34. Within the past 52 weeks, ICU’s price has moved between $1.21 and $20.00.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company achieved an average annual earnings per share of 76.92%. With a float of $8.51 million, this company’s outstanding shares have now reached $8.72 million.

The firm has a total of 19 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -13216.3%, and the pretax margin is -18390.37%.

SeaStar Medical Holding Corp (ICU) Breakdown of a Key Holders of the stock

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of SeaStar Medical Holding Corp is 2.45%, while institutional ownership is 2.07%. The most recent insider transaction that took place on Aug 15 ’24, was worth 52,396. In this transaction Director of this company bought 10,000 shares at a rate of $5.24, taking the stock ownership to the 30,000 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 10,000 for $4.35, making the entire transaction worth $43,521. This insider now owns 20,000 shares in total.

SeaStar Medical Holding Corp (ICU) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 76.92% per share during the next fiscal year.

SeaStar Medical Holding Corp (NASDAQ: ICU) Trading Performance Indicators

SeaStar Medical Holding Corp (ICU) is currently performing well based on its current performance indicators. A quick ratio of 0.55 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 77.86.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.59, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.03 in one year’s time.

Technical Analysis of SeaStar Medical Holding Corp (ICU)

Analysing the last 5-days average volume posted by the [SeaStar Medical Holding Corp, ICU], we can find that recorded value of 0.33 million was lower than the volume posted last year of 0.41 million. As of the previous 9 days, the stock’s Stochastic %D was 8.62%. Additionally, its Average True Range was 0.22.

During the past 100 days, SeaStar Medical Holding Corp’s (ICU) raw stochastic average was set at 2.15%, which indicates a significant decrease from 2.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 133.17% in the past 14 days, which was higher than the 106.18% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.8318, while its 200-day Moving Average is $3.8785. Now, the first resistance to watch is $1.4067. This is followed by the second major resistance level at $1.5633. The third major resistance level sits at $1.6567. If the price goes on to break the first support level at $1.1567, it is likely to go to the next support level at $1.0633. Now, if the price goes above the second support level, the third support stands at $0.9067.

SeaStar Medical Holding Corp (NASDAQ: ICU) Key Stats

Market capitalization of the company is 10.90 million based on 8,721K outstanding shares. Right now, sales total 140 K and income totals -24,830 K. The company made 70 K in profit during its latest quarter, and -4,420 K in sales during its previous quarter.